SCHEMBL29289348

SCHEMBL29289348

NC(=O)c1c(O)nc[nH]c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GDA Q9Y2T3 1/20 0.42
POLB P06746 1/20 0.39
ALDH1A1 P00352 2/20 0.39
PIM1 P11309 1/20 0.38
PARP1 P09874 5/20 0.37
BCL2 P10415 1/20 0.37
MCL1 Q07820 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 3/20 0.33
TSHR P16473 3/20 0.33
SLC2A1 P11166 1/20 0.33
PAX8 Q06710 1/20 0.33
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
PDPK1 O15530 1/20 0.33
CA12 O43570 1/20 0.33
ALOX15 P16050 1/20 0.33
CA9 Q16790 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29812517 0.78 GDA (0.41) GDAALDH1A1PIM1PARP1SMN1; SMN2
SCHEMBL13219030 0.72
SCHEMBL20536023 0.72 GDA (0.42) GDAALDH1A1PIM1PARP1BCL2
SCHEMBL460243 0.72 GDA (0.42) GDAALDH1A1PIM1PARP1BCL2
SCHEMBL6765002 0.68
SCHEMBL10338263 0.68 THRB (0.53) POLBALDH1A1SMN1; SMN2LMNARAB9A
SCHEMBL26672974 0.67 GDA (0.41) GDAALDH1A1PIM1PARP1BCL2
SCHEMBL24338103 0.66 POLB (0.43) GDAPOLBALDH1A1PIM1PARP1
SCHEMBL21393631 0.64 GDA (0.43) GDAALDH1A1PIM1PARP1BCL2
SCHEMBL14434857 0.64 CYP1A2 (0.41) POLBALDH1A1PARP1BCL2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476642-B Compounds and their use for reducing uric acid levels 阿奎斯特有限责任公司 2022-01-25 CN disclosed
CN-109476642-A COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS 阿奎斯特有限责任公司 2019-03-15 CN disclosed